Carmat SA

Paris Stock Exchange ALCAR.PA

Carmat SA Price to Sales Ratio (P/S) on January 14, 2025: 15.84

Carmat SA Price to Sales Ratio (P/S) is 15.84 on January 14, 2025, a -80.69% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Carmat SA 52-week high Price to Sales Ratio (P/S) is 84.86 on January 16, 2024, which is 435.71% above the current Price to Sales Ratio (P/S).
  • Carmat SA 52-week low Price to Sales Ratio (P/S) is 14.14 on December 20, 2024, which is -10.75% below the current Price to Sales Ratio (P/S).
  • Carmat SA average Price to Sales Ratio (P/S) for the last 52 weeks is 40.82.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
Paris Stock Exchange: ALCAR.PA

Carmat SA

CEO Mr. Stephane Piat
IPO Date July 13, 2010
Location France
Headquarters 36, avenue de l'Europe
Employees 162
Sector Consumer Discretionary
Industries
Description

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It The company was founded in 2008 and is headquartered in Vélizy-Villacoublay, France.

Similar companies

ALCLS.PA

Cellectis S.A.

USD 1.74

-2.29%

NANO.PA

Nanobiotix S.A.

USD 3.05

0.95%

GNFT.PA

Genfit S.A.

USD 3.40

-0.30%

IPH.PA

Innate Pharma S.A.

USD 1.88

-0.49%

StockViz Staff

January 15, 2025

Any question? Send us an email